INJ Price Eyes $7 as Bullish Structure Meets New USDC Standard Integration
Covered by 1 source · 1 article
Injective (INJ) is showing signs of a broader recovery as the token holds key support and trades within an ascending channel. Rising volume and open interest are reinforcing market participation, while Injective’s new USDC standard could st…
Covered by
